Cargando…
Erratum in: SZN-413, a FZD4 Agonist, as a Potential Novel Therapeutic for the Treatment of Diabetic Retinopathy
| Formato: | Online Artículo Texto |
|---|---|
| Lenguaje: | English |
| Publicado: |
The Association for Research in Vision and Ophthalmology
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9587469/ https://www.ncbi.nlm.nih.gov/pubmed/36259679 http://dx.doi.org/10.1167/tvst.11.10.31 |
| _version_ | 1784813908217823232 |
|---|---|
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9587469 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | The Association for Research in Vision and Ophthalmology |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-95874692022-10-23 Erratum in: SZN-413, a FZD4 Agonist, as a Potential Novel Therapeutic for the Treatment of Diabetic Retinopathy Transl Vis Sci Technol Erratum The Association for Research in Vision and Ophthalmology 2022-10-19 /pmc/articles/PMC9587469/ /pubmed/36259679 http://dx.doi.org/10.1167/tvst.11.10.31 Text en Copyright 2022 The Authors https://creativecommons.org/licenses/by-nc-nd/4.0/This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License. |
| spellingShingle | Erratum Erratum in: SZN-413, a FZD4 Agonist, as a Potential Novel Therapeutic for the Treatment of Diabetic Retinopathy |
| title | Erratum in: SZN-413, a FZD4 Agonist, as a Potential Novel Therapeutic for the Treatment of Diabetic Retinopathy |
| title_full | Erratum in: SZN-413, a FZD4 Agonist, as a Potential Novel Therapeutic for the Treatment of Diabetic Retinopathy |
| title_fullStr | Erratum in: SZN-413, a FZD4 Agonist, as a Potential Novel Therapeutic for the Treatment of Diabetic Retinopathy |
| title_full_unstemmed | Erratum in: SZN-413, a FZD4 Agonist, as a Potential Novel Therapeutic for the Treatment of Diabetic Retinopathy |
| title_short | Erratum in: SZN-413, a FZD4 Agonist, as a Potential Novel Therapeutic for the Treatment of Diabetic Retinopathy |
| title_sort | erratum in: szn-413, a fzd4 agonist, as a potential novel therapeutic for the treatment of diabetic retinopathy |
| topic | Erratum |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9587469/ https://www.ncbi.nlm.nih.gov/pubmed/36259679 http://dx.doi.org/10.1167/tvst.11.10.31 |